Detalhe da pesquisa
1.
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
Mult Scler
; 26(3): 312-321, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741108
2.
Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.
Mult Scler
; 26(7): 815-828, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31094280
3.
Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.
Brain
; 141(11): 3115-3129, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312381
4.
Moyamoya masquerading as relapsing remitting multiple sclerosis.
Neurol Sci
; 40(3): 635-637, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30368694
5.
Primary progressive multiple sclerosis to be treated with ocrelizumab: a mistaken case of cobalamin deficiency.
BMJ Case Rep
; 12(5)2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092497